Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

A comparative analysis of outpatient costs in HIV treatment programs.

Sarti FM, Nishijima M, Campino AC, Cyrillo DC.

Rev Assoc Med Bras (1992). 2012 Sep-Oct;58(5):561-7.

2.

Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA.

PLoS Med. 2007 Nov 13;4(11):e305.

3.

What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria?

Aliyu HB, Chuku NN, Kola-Jebutu A, Abubakar Z, Torpey K, Chabikuli ON.

J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):221-5.

PMID:
22820805
4.

The lifetime cost of current human immunodeficiency virus care in the United States.

Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein MC, Seage GR 3rd, Moore RD, Freedberg KA.

Med Care. 2006 Nov;44(11):990-7. Review.

PMID:
17063130
5.

Costs of intermittent versus continuous antiretroviral therapy in patients with controlled HIV infection: a substudy of the ANRS 106 Window Trial.

Charreau I, Jeanblanc G, Tangre P, Boyer L, Saouzanet M, Marchou B, Molina JM, Aboulker JP, Durand-Zaleski I; ANRS 106 Study Group.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):416-21. doi: 10.1097/QAI.0b013e31818a657c.

PMID:
18931625
6.

Financial burden of health care for HIV/AIDS patients in Vietnam.

Tran BX, Duong AT, Nguyen LT, Hwang J, Nguyen BT, Nguyen QT, Nong VM, Vu PX, Ohinmaa A.

Trop Med Int Health. 2013 Feb;18(2):212-8. doi: 10.1111/tmi.12032. Epub 2012 Dec 5.

7.

Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs.

Zhou F, Kominski GF, Qian HZ, Wang J, Duan S, Guo Z, Zhao X.

BMC Med. 2011 Jan 17;9:6. doi: 10.1186/1741-7015-9-6.

8.

Costs of care provided in a university hospital for children exposed to or infected with the HIV/AIDS.

Marques HH, Couttolenc BF, Latorre Mdo R, Aquino MZ, Aveiro MI, Pluciennik AM.

Cad Saude Publica. 2007;23 Suppl 3:S402-13.

9.

The Brazilian experiment: HIV drugs for all.

Flaer PJ, Younis MZ.

J Health Care Finance. 2009 Winter;36(2):90-6.

PMID:
20499725
10.

The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

Levy A, Johnston K, Annemans L, Tramarin A, Montaner J.

Pharmacoeconomics. 2010;28 Suppl 1:35-47. doi: 10.2165/11587430-000000000-00000. Review.

PMID:
21182342
11.

Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWER.

Hill AM, Gebo K, Hemmett L, Löthgren M, Allegri G, Smets E.

Pharmacoeconomics. 2010;28 Suppl 1:169-81. doi: 10.2165/11587510-000000000-00000.

PMID:
21182350
12.

The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.

Krentz HB, Auld MC, Gill MJ; HIV Economic Study Group.

CMAJ. 2003 Jul 22;169(2):106-10.

13.

[Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].

Kuhlmann A, Mittendorf T, Hower M, Heiken H, Gerschmann S, Klauke S, Lutz T, Bogner J, Degen O, van Lunzen J, Bachmann C, Stellbrink HJ, Schmidt W, Leistner I, Mahlich J, Ranneberg B, Stoll M.

Gesundheitswesen. 2015 Jun;77(6):e133-42. doi: 10.1055/s-0034-1381993. Epub 2014 Sep 23. German.

PMID:
25247761
14.

Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.

Fleishman JA, Gebo KA, Reilly ED, Conviser R, Christopher Mathews W, Todd Korthuis P, Hellinger J, Rutstein R, Keiser P, Rubin H, Moore RD; HIV Research Network.

Med Care. 2005 Sep;43(9 Suppl):III40-52.

PMID:
16116308
15.

Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.

Tagar E, Sundaram M, Condliffe K, Matatiyo B, Chimbwandira F, Chilima B, Mwanamanga R, Moyo C, Chitah BM, Nyemazi JP, Assefa Y, Pillay Y, Mayer S, Shear L, Dain M, Hurley R, Kumar R, McCarthy T, Batra P, Gwinnell D, Diamond S, Over M.

PLoS One. 2014 Nov 12;9(11):e108304. doi: 10.1371/journal.pone.0108304. eCollection 2014.

16.
17.

Healthcare utilization of patients accessing an African national treatment program.

Harling G, Orrell C, Wood R.

BMC Health Serv Res. 2007 Jun 7;7:80.

18.

Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital).

Kevany S, Meintjes G, Rebe K, Maartens G, Cleary S.

S Afr Med J. 2009 May;99(5):320-5.

PMID:
19588792
19.

The costs of HIV antiretroviral therapy adherence programs and impact on health care utilization.

Sansom SL, Anthony MN, Garland WH, Squires KE, Witt MD, Kovacs Andrea A, Larsen RA, Valencia R, Pals SL, Hader S, Weidle PJ, Wohl AR.

AIDS Patient Care STDS. 2008 Feb;22(2):131-8. doi: 10.1089/apc.2006.0216.

PMID:
18260804
20.

Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.

Blair JM, Fagan JL, Frazier EL, Do A, Bradley H, Valverde EE, McNaghten A, Beer L, Zhang S, Huang P, Mattson CL, Freedman MS, Johnson CH, Sanders CC, Spruit-McGoff KE, Heffelfinger JD, Skarbinski J; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC.

MMWR Suppl. 2014 Jun 20;63(5):1-22.

PMID:
24941443

Supplemental Content

Support Center